SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-129285
Filing Date
2023-12-26
Accepted
2023-12-26 17:28:41
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B3 tm2329199-3_424b3.htm 424B3 4521343
2 GRAPHIC lg_trisalus-4c.jpg GRAPHIC 23550
3 GRAPHIC fc_treating-4clr.jpg GRAPHIC 264595
4 GRAPHIC fc_usannual-4clr.jpg GRAPHIC 234049
5 GRAPHIC tb_clinicaldevelopment-4clr.jpg GRAPHIC 83606
6 GRAPHIC fc_clinical-4clr.jpg GRAPHIC 161613
7 GRAPHIC fc_trisalus-4clr.jpg GRAPHIC 130002
8 GRAPHIC tb_comparison-4c.jpg GRAPHIC 366846
  Complete submission text file 0001104659-23-129285.txt   6252146
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Filer) CIK: 0001826667 (see all company filings)

IRS No.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-276070 | Film No.: 231514206
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)